AnaptysBio (ANAB) Stock Chart & Stock Price History $20.11 +0.11 (+0.55%) Closing price 04:00 PM EasternExtended Trading$20.10 -0.01 (-0.05%) As of 04:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AnaptysBio Stock Price Performance The AnaptysBio (ANAB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 40.41%, with a year-to-date return of 51.89%. In the past month, the stock has decreased 23.24%, reflecting recent market activity. As of the latest close, AnaptysBio traded at $20.00 with a market cap of $560 million and volume of 524,163 shares. Five years ago, the stock traded at $17.43, representing a 15.38% increase over that period. At the time, it had a market cap of $481.99 million and a volume of 252,500 shares. Receive ANAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.28%1 Month Performance-23.24%3 Month Performance+0.40%Year-To-Date Performance+51.89%1 Year Performance-40.41%5 Year Performance+15.38% ANAB Stock Chart for Tuesday, August, 12, 2025 ANAB Chart by TradingView AnaptysBio Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/12/2025$20.00$20.11+0.55%$20.40$19.55432,780 shs$563.08 million08/11/2025$21.03$20.00-4.90%$21.16$19.87524,163 shs$560 million08/08/2025$20.37$21.03+3.24%$21.24$19.201.05 million shs$617.86 million08/07/2025$22.54$20.37-9.63%$23.67$20.26528,984 shs$598.47 million08/06/2025$23.69$22.54-4.85%$23.94$22.40473,838 shs$662.23 million08/05/2025$24.23$23.69-2.23%$24.72$23.44391,355 shs$696.01 million08/04/2025$24.69$24.23-1.86%$25.61$24.07257,256 shs$711.88 million08/01/2025$24.55$24.69+0.57%$24.93$24.00326,863 shs$725.39 million07/31/2025$24.98$24.55-1.72%$25.26$24.39507,353 shs$721.28 million07/30/2025$26.22$24.98-4.73%$26.57$23.61774,903 shs$733.91 million Get the Latest News and Ratings for ANAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter. 07/29/2025$26.59$26.22-1.39%$27.00$26.00306,185 shs$770.34 million07/28/2025$26.94$26.59-1.30%$27.40$26.57380,835 shs$781.21 million07/25/2025$26.99$26.94-0.19%$27.47$26.61506,614 shs$791.50 million07/24/2025$27.00$26.99-0.04%$28.50$26.45517,706 shs$792.97 million07/23/2025$26.21$27.00+3.01%$27.38$26.16822,451 shs$793.26 million07/22/2025$26.17$26.21+0.15%$26.51$25.48480,670 shs$770.05 million07/21/2025$25.92$26.17+0.96%$27.34$25.74495,479 shs$768.88 million07/18/2025$26.68$25.92-2.85%$26.92$25.84334,038 shs$761.53 million07/17/2025$26.86$26.68-0.67%$27.47$26.66463,673 shs$783.86 million07/16/2025$26.63$26.86+0.86%$27.40$26.36576,603 shs$789.15 million07/15/2025$26.95$26.63-1.19%$27.22$26.12341,750 shs$782.39 million07/14/2025$26.20$26.95+2.86%$27.12$26.03244,155 shs$791.79 million07/11/2025$26.09$26.20+0.42%$26.70$25.44338,707 shs$769.76 million Related Companies Apellis Pharmaceuticals Stock Chart MorphoSys Stock Chart Kymera Therapeutics Stock Chart Ultragenyx Pharmaceutical Stock Chart Immunovant Stock Chart Alvotech Stock Chart Crinetics Pharmaceuticals Stock Chart Mirum Pharmaceuticals Stock Chart Catalyst Pharmaceuticals Stock Chart Gemini Therapeutics Stock Chart Receive ANAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ANAB) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredElon Musk: “Nothing happens without this…”Lithium has fueled the EV boom, but another resource is even more critical. Without it, over 20 million electr...Behind the Markets | SponsoredSell these stocks now—what to buy insteadSell these stocks now—Here’s what to buy instead Wall Street legend Marc Chaikin says you must know these 3...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredAmericans are rushing into gold (but not billionaires!)Billionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AnaptysBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AnaptysBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access